A detailed history of Lmcg Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lmcg Investments, LLC holds 171,848 shares of ABBV stock, worth $28.4 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
171,848
Previous 172,051 0.12%
Holding current value
$28.4 Million
Previous $29.5 Million 15.0%
% of portfolio
2.06%
Previous 1.73%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $33,259 - $40,463
-203 Reduced 0.12%
171,848 $33.9 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $488,362 - $570,297
3,155 Added 1.87%
172,051 $29.5 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $221,510 - $252,390
-1,386 Reduced 0.81%
168,896 $30.8 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $410,460 - $462,275
2,983 Added 1.78%
170,282 $26.4 Million
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $300,310 - $347,653
-2,248 Reduced 1.33%
167,299 $24.9 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $3.09 Million - $3.84 Million
23,315 Added 15.94%
169,547 $22.8 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $562,677 - $648,007
-3,891 Reduced 2.59%
146,232 $23.3 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $273,577 - $328,090
-1,978 Reduced 1.3%
150,123 $24.3 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $765,399 - $877,862
-5,703 Reduced 3.61%
152,101 $20.4 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $236,706 - $300,931
-1,720 Reduced 1.08%
157,804 $24.2 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $21.1 Million - $26.1 Million
159,524 New
159,524 $25.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lmcg Investments, LLC Portfolio

Follow Lmcg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lmcg Investments, LLC with notifications on news.